Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122621802 | 12262180 | 2 | F | 20151113 | 20160719 | 20160413 | 20160721 | EXP | GB-MHRA-EYC 00137487 | GB-GLAXOSMITHKLINE-GB2016046612 | GLAXOSMITHKLINE | 33.00 | YR | F | Y | 0.00000 | 20160721 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122621802 | 12262180 | 1 | PS | CEFUROXIME. | CEFUROXIME | 1 | Intravenous (not otherwise specified) | 1.5 G, UNK | 50605 | 1.5 | G |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122621802 | 12262180 | 1 | Antibiotic prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122621802 | 12262180 | HO |
| 122621802 | 12262180 | OT |
| 122621802 | 12262180 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122621802 | 12262180 | Anaphylactic reaction | |
| 122621802 | 12262180 | Exposure during pregnancy | |
| 122621802 | 12262180 | Live birth |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122621802 | 12262180 | 1 | 20151113 | 20151113 | 0 |